The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens
Open accessAbstract
Genetic screens help infer gene function in mammalian cells, but it has remained difficult to assay complex phenotypes-such as transcriptional profiles-at scale. Here, we develop Perturb-seq, combining single-cell RNA sequencing (RNA-seq) and clustered regularly interspaced short palindromic repeats (CRISPR)-based perturbations to perform many such assays in a pool. We demonstrate Perturb-seq by analyzing 200,000 cells in immune cells and cell lines, focusing on transcription factors regulating the response of dendritic cells to lipopolysaccharide (LPS). Perturb-seq accurately identifies individual gene targets, gene signatures, and cell states affected by individual perturbations and their genetic interactions. We posit new functions for regulators of differentiation, the anti-viral response, and mitochondrial function during immune activation. By decomposing many high content measurements into the effects of perturbations, their interactions, and diverse cell metadata, Perturb-seq dramatically increases the scope of pooled genomic assays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“suggesting multiplexing reduces technical effects due to separate sample processing22, 23.”
From Multiplexed droplet single-cell RNA-sequencing using natural genetic variation (2018) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These models had shown strong performance in post-perturbation RNA-seq prediction tasks using Perturb-seq-based genetic perturbation benchmarks [12].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, single-cell RNA-sequencing pooled CRISPR screens can simultaneously sequence transcriptomes and sgRNAs from individual cells, enabling a comprehensive analysis of sgRNA-specific effects on genetic regulatory networks at single-cell resolution32–34.”
From Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions (2025) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“along with the ability to couple these measurements with systematic perturbations.27–29”
From How to build the virtual cell with artificial intelligence: Priorities and opportunities (2024) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“identified five methods commonly in use: the default Seurat [19] FindMarkers() function based on the Wilcoxon test (Seurat-Wilcox), MIMOSCA [1], a t-test on the library-size-normalized expressions [10], MAST [20], and a Kolmogorov-Smirnov (KS) test on the library-size-normalized expressions [21]”
From Robust differential expression testing for single-cell CRISPR screens at low multiplicity of infection (2024) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“two alternative methods - Perturb-seq and CRISP-seq were published that use transcribed barcodes for single-cell CRISPR screening 14-16 .”
From Pooled CRISPR screening with single-cell transcriptome readout. (2017) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Perturb-seq is a multiplexed lentiviral platform combining CRISPR-based genetic perturbations and single-cell RNA-seq (scRNA-seq) to accurately identify transcriptional profiles and single-cell states affected by individual genetic perturbations, extending beyond simple bulk cellular growth phenotypes32–34 (Fig. 4A).”
From Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions (2025) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“Although CRISPR screening coupled with single-cell transcriptomic readout provides unprecedented resolution for phenotypic characterization14–16, such approaches have not been fully explored in organoids.”
From Single-cell brain organoid screening identifies developmental defects in autism (2023) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“Next, we investigate whether SenCID can be used in high-throughput single-cell CRISPR screens, such as CROP-seq117,118 or Perturb-seq119,120 to identify genome-wide senescence trigger and suppressor genes.”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [119]
In the citing paper
“As we previously showed1, detection of a sgRNA in a cell does not necessarily mean that this cell is perturbed, either because the sgRNA has not perturbed the gene, or the perturbation does not have an impact.”
From Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion (2021) · cites this paper as [1]
In the citing paper
“The perturbations also altered the expression of the ICR program, which we originally defined in patients1, in both co-culture (Fig. 4e) and in response to IFN γ treatment (Fig. 4f).”
From Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion (2021) · cites this paper as [1]
In the citing paper
“In recent years, CRISPR screens have been combined with single-cell RNA-sequencing to measure the effects of genetic perturbations on gene expression across the transcriptome2–5.”
From Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens (2021) · cites this paper as [4]
In the citing paper
“differential gene expression testing was restricted to pre-defined candidate genes7,9,10 or genes were grouped into gene signatures3,4,6,8.”
From Targeted Perturb-seq enables genome-scale genetic screens in single cells (2020) · cites this paper as [4]
In the citing paper
“Second, lowly expressed genes and small effects are not measured efficiently4,7–9.”
From Targeted Perturb-seq enables genome-scale genetic screens in single cells (2020) · cites this paper as [4]
In the citing paper
“First, costs are prohibitive even for non-genome scale screens4.”
From Targeted Perturb-seq enables genome-scale genetic screens in single cells (2020) · cites this paper as [4]
In the citing paper
“Alternatively cells were mapped to known reference cell (sub)types or states4,5,11,12, making effective use only of cell-state or cell-type specific marker genes.”
From Targeted Perturb-seq enables genome-scale genetic screens in single cells (2020) · cites this paper as [4]
In the citing paper
“the implications of template switching at longer distances (e.g. the 2.5 kb+ separation between sgRNAs and barcodes in the pLGB-scKO, CRISP-seq, Perturb-seq, and Mosaic-seq vectors3–6), as well as for scRNA-seq study designs specifically, remain unexplored.”
From On the design of CRISPR-based single-cell molecular screens (2018) · cites this paper as [5]
In the citing paper
“It was altogether avoided by Adamson et al.4 through arrayed lentiviral production, but pooled lentiviral production was performed in some or all experiments of the other reports3,5,6.”
From On the design of CRISPR-based single-cell molecular screens (2018) · cites this paper as [5]
In the citing paper
“This risk was noted by Adamson et al.4 and Dixit et al.5.”
From On the design of CRISPR-based single-cell molecular screens (2018) · cites this paper as [5]
In the citing paper
“CROP-seq7 differs from the other methods3–6 in not relying on pairing of sgRNAs and barcodes. Instead, the sgRNA itself serves as a barcode, as part of an overlapping Pol II transcript.”
From On the design of CRISPR-based single-cell molecular screens (2018) · cites this paper as [5]
In the citing paper
“Similar advances in the ability to measure transcriptomes in single cells have recently allowed high-throughput genetic screens coupled with simultaneous transcriptome phenotyping (Dixit et al., 2016; Adamson et al., 2016; Jaitin et al., 2016; Datlinger et al., 2017).”
From Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks (2019) · cites this paper as Dixit et al., 2016
In the citing paper
“A particularly scalable approach to differential expression is Perturb-Seq, which combines single-cell RNA sequencing with a high-throughput CRISPR screen1-4.”
From Transcriptome-wide analysis of differential expression in perturbation atlases (2025) · cites this paper as [1]
In the citing paper
“Cell-based statistical measures can be used to identify successfully perturbed cells but do not currently quantify similarity of perturbation effects2,9.”
From scPerturb: harmonized single-cell perturbation data (2024) · cites this paper as [2]
In the citing paper
“Some initial groundbreaking technologies in this field include Perturb-seq [7] and CRISP-seq [8], which are highly parallelised single-cell technologies built on CRISPR-pooled screens.”
From A mini-review on perturbation modelling across single-cell omic modalities (2024) · cites this paper as [7]
In the citing paper
“For example, Perturb-seq pairs CRISPR-based screens with single-cell RNA sequencing (5–8). Each individual cell is in effect an independent experiment connecting a genetic perturbation to its transcriptional consequences, allowing hundreds of thousands of parallel measurements (9, 10).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [7]
In the citing paper
“One possible strategy to address the scale of genetic interactions is to pursue a split experimental/computational approach, in which only a subset of interactions are sampled (either randomly or through “compressed” experimental designs (28)) and the remainder are predicted computationally (Fig. 6A) (7, 29, 30).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [7]
In the citing paper
“Perturb-seq provides a scalable means of constraining these types of searches (7), enabling exploration of the GI landscape.”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [7]
In the citing paper
“This provides a complementary approach to efforts based on composite measurements, compressed sensing, and rich readouts to predict unmeasured GIs (7, 28).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [7]
In the citing paper
“We and others have established that functionally related genes interact similarly—in geometric terms the GI manifold is therefore highly constrained, enabling imputation strategies (1, 2, 7, 12, 29).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [7]
In the citing paper
“Recently, CRISPR screens have been coupled with single cell RNA sequencing (scRNA-seq), and vector-encoded RNA used as a barcode”
From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Dixit et al., 2016
In the citing paper
“Several groups have incorporated scRNA-seq into pooled screens to obtain more comprehensive phenotyping than previously possible, and to achieve single cell resolution (Adamson et al., 2016; Datlinger et al., 2017; Dixit et al., 2016; Jaitin et al., 2016).”
From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Dixit et al., 2016
In the citing paper
“Coupling pooled CRISPR gene knockouts with single cell RNA sequencing provides a powerful approach to assess the effect of each gene perturbation on cell state (Adamson et al., 2016; Datlinger et al., 2017; Dixit et al., 2016; Jaitin et al., 2016).”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Dixit et al., 2016
In the citing paper
“For example, single-cell RNA sequencing (scRNA-seq) coupled with pooled CRISPR screens offers much promise for analysing the genetic regulation of cell identity2–4, but cannot be readily used in many biological contexts.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [3]
In the citing paper
“Dixit et al. has 24 transcription factors perturbed in dendritic cells and 25 cell cycle genes targeted in K562 cells, while Papalexi et al. has 25 PD-L1 regulators perturbed in THP-1 cells.”
From SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics (2023) · cites this paper as [32]
In the citing paper
“For the Perturb-seq validation, we used datasets from Dixit et al.32 and Papalexi et al.31”
From SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics (2023) · cites this paper as [32]
In the citing paper
“we employed a permutation test as in Dixit et al.32”
From SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics (2023) · cites this paper as [32]
In the citing paper
“Complex morphological phenotypes that cannot be detected by FACS, but are apparent by fluorescence microscopy, can be evaluated in pooled optical screens78,79.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [79]
In the citing paper
“To identify which perturbation is applied to each cell, CRISP-seq, Perturb-seq and Mosaic-seq use poly-A barcodes, which are then computationally linked to the gRNA.”
From Mapping gene regulatory networks from single-cell omics data (2018) · cites this paper as [89]
In the citing paper
“In Perturb-seq, a computational method is developed based on a linear model (Multi-Input-Multi-Output-Single-Cell-Analysis, MIMOSCA), which allows studying the impact of individual perturbations on gene expression and the marginal contributions of the genetic interactions.”
From Mapping gene regulatory networks from single-cell omics data (2018) · cites this paper as [89]
In the citing paper
“They present interesting proof of principle applications, exploring the effect of a few dozen perturbations per experiment (typically targeting 10–30 genes, TFs or enhancers), and all expect that the number of elements screened will increase in future applications.”
From Mapping gene regulatory networks from single-cell omics data (2018) · cites this paper as [89]
In the citing paper
“Several methods have been developed using pooled CRISPR/CAS9 genome editing to introduce a large amount of perturbations in a population of cells, the effects of which can subsequently be measured using single-cell transcriptomics. These methods include CRISP-seq [88], Perturb-seq [89, 90], CROP-seq [91] and Mosaic-seq [92].”
From Mapping gene regulatory networks from single-cell omics data (2018) · cites this paper as [89]
In the citing paper
“Similarly, CRISP-seq and Perturb-seq were also applied in a knockout context focused on identifying key regulators of the immune response and their combinatorial effects.”
From Mapping gene regulatory networks from single-cell omics data (2018) · cites this paper as [89]
In the citing paper
“Furthermore, CRISPR–Cas gene editing coupled with single-cell transcriptome readouts15–17 enables pooled genetic perturbation experiments in vivo18.”
From Inferring and perturbing cell fate regulomes in human brain organoids (2023) · cites this paper as [15]
In the citing paper
“Combined with complex readouts–including high-content imaging128 and single-cell transcriptomics and epigenomics129,130–these methods can generate empirical ‘truth’ data, supporting the development of in silico models to predict causal variants, effector transcripts126 and cellular effects.”
From A brief history of human disease genetics (2020) · cites this paper as [129]
In the citing paper
“massively parallel scRNA-seq methods, such as Drop-seq7 and related methods8–10 can be readily applied at scale11 in a cost-effective manner12, but require intact single cell suspension as input.”
From Massively parallel single-nucleus RNA-seq with DroNc-seq (2017) · cites this paper as [8]
In the citing paper
“One possible solution to this problem is the combination of single‐cell RNA‐seq with targeted CRISPR screens to produce more impactful perturbations at high throughput (Adamson et al, 2016; Dixit et al, 2016; Jaitin et al, 2016; Datlinger et al, 2017).”
From Using single-cell genomics to understand developmental processes and cell fate decisions (2018) · cites this paper as Dixit et al, 2016
In the citing paper
“Perturb-seq is one of these methods, in which thousands of CRISPR-mediated perturbations and mRNA profiles are analysed in a single experiment of 200,000 cells82.”
From The technological landscape and applications of single-cell multi-omics (2023) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
Self-citationLamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Self-citationMaps of random walks on complex networks reveal community structure
Rosvall, M., & Bergstrom, C. T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706851105 · Cited by 4,583
Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells
Klein, A. M., Mazutis, L., Akartuna, I., Tallapragada, N., Veres, A., Li, V., Peshkin, L., Weitz, D. A., & Kirschner, M. W. (2015) · Cell · doi:10.1016/j.cell.2015.04.044 · Cited by 3,356
Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq
Zeisel, A., Muñoz-Manchado, A. B., Codeluppi, S., Lönnerberg, P., La Manno, G., Juréus, A., Marques, S., Munguba, H., He, L., Betsholtz, C., et al. (2015) · Science · doi:10.1126/science.aaa1934 · Cited by 3,124
Cited by
Sorted by citations
Items 301–400 of 1,010
A guide to systems-level immunomics
Bonaguro, L., Schulte-Schrepping, J., Ulas, T., Aschenbrenner, A. C., Beyer, M., & Schultze, J. L. (2022) · Nature Immunology · doi:10.1038/s41590-022-01309-9 · Cited by 80
Optimal transport for single-cell and spatial omics
Bunne, C., Schiebinger, G., Krause, A., Regev, A., & Cuturi, M. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00334-2 · Cited by 71
Self-citationStrategies for genetic manipulation of adult stem cell-derived organoids
Menche, C., & Farin, H. F. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00609-8 · Cited by 72
Jariani, A., Vermeersch, L., Cerulus, B., Perez-Samper, G., Voordeckers, K., Brussel, T. V., Thienpont, B., Lambrechts, D., & Verstrepen, K. J. (2020) · eLife · doi:10.7554/elife.55320 · Cited by 71
Using Large Datasets to Understand Nanotechnology
Paunovska, K., Loughrey, D., Sago, C. D., Langer, R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201902798 · Cited by 69
Inference and effects of barcode multiplets in droplet-based single-cell assays
Lareau, C. A., Ma, S., Duarte, F. M., & Buenrostro, J. D. (2020) · Nature Communications · doi:10.1038/s41467-020-14667-5 · Cited by 64
Transcriptome-wide analysis of differential expression in perturbation atlases
Nadig, A., Replogle, J. M., Pogson, A. N., Murthy, M., McCarroll, S. A., Weissman, J. S., Robinson, E. B., & O’Connor, L. J. (2025) · Nature Genetics · doi:10.1038/s41588-025-02169-3 · Cited by 70
Self-citationIsolating salient variations of interest in single-cell data with contrastiveVI
Weinberger, E., Lin, C., & Lee, S.-I. (2023) · Nature Methods · doi:10.1038/s41592-023-01955-3 · Cited by 66
Detecting genome-wide directional effects of transcription factor binding on polygenic disease risk
Reshef, Y. A., Finucane, H. K., Kelley, D. R., Gusev, A., Kotliar, D., Ulirsch, J. C., Hormozdiari, F., Nasser, J., O’Connor, L., van de Geijn, B., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0196-7 · Cited by 68
High-Throughput Approaches to Pinpoint Function within the Noncoding Genome
Montalbano, A., Canver, M. C., & Sanjana, N. E. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.017 · Cited by 68
Single-Cell Techniques and Deep Learning in Predicting Drug Response
Wu, Z., Lawrence, P. J., Ma, A., Zhu, J., Xu, D., & Ma, Q. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.10.004 · Cited by 72
Gene editing and its applications in biomedicine
Li, G., Li, X., Zhuang, S., Wang, L., Zhu, Y., Chen, Y., Sun, W. C., Wu, Z., Zhou, Z. L., Chen, J., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2057-0 · Cited by 66
Self-citationGenome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
McTague, A., Rossignoli, G., Ferrini, A., Barral, S., & Kurian, M. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.630600 · Cited by 67
Hegde, M., Strand, C., Hanna, R. E., & Doench, J. G. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197547 · Cited by 66
The use of new CRISPR tools in cardiovascular research and medicine
Nishiga, M., Liu, C., Qi, L. S., & Wu, J. C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00669-3 · Cited by 71
Advances and applications in single-cell and spatial genomics
Wang, J., Ye, F., Chai, H., Jiang, Y., Wang, T., Ran, X., Xia, Q., Xu, Z., Fu, Y., Zhang, G., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2770-x · Cited by 70
Transcriptional determination and functional specificity of myeloid cells: making sense of diversity
Monticelli, S., & Natoli, G. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.51 · Cited by 63
Signature-based approaches for informed drug repurposing: targeting CNS disorders
Shukla, R., Henkel, N., Alganem, K., Hamoud, A.-R. A., Reigle, J. K., Alnafisah, R. S., Eby, H., Imami, A. S., Creeden, J. F., Miruzzi, S. A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0752-6 · Cited by 66
Multiplexed, image-based pooled screens in primary cells and tissues with PerturbView
Kudo, T., Meireles, A. M., Moncada, R., Chen, Y., Wu, P., Gould, J., Hu, X., Kornfeld, O., Jesudason, R., Foo, C., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02391-0 · Cited by 74
Self-citationAarts, M., Georgilis, A., Beniazza, M., Beolchi, P., Banito, A., Carroll, T., Kulisic, M., Kaemena, D. F., Dharmalingam, G., Martin, N., et al. (2017) · Genes & Development · doi:10.1101/gad.297796.117 · Cited by 64
Tissue-specific enhancer–gene maps from multimodal single-cell data identify causal disease alleles
Sakaue, S., Weinand, K., Isaac, S., Dey, K. K., Jagadeesh, K. A., Kanai, M., Watts, G. F. M., Zhu, Z., Accelerating Medicines Partnership® RA/SLE Program and Network, Albrecht, J., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01682-1 · Cited by 65
Tolios, A., Rivas, J. D. L., Hovig, E. J., Trouillas, P., Scorilas, A., & Mohr, T. T. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100662 · Cited by 64
Frequent sgRNA-barcode recombination in single-cell perturbation assays
Xie, S., Cooley, A., Armendariz, D., Zhou, P., & Hon, G. C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198635 · Cited by 63
Parekh, U., Wu, Y., Zhao, D., Worlikar, A., Shah, N., Zhang, K., & Mali, P. (2018) · Cell Systems · doi:10.1016/j.cels.2018.10.008 · Cited by 67
Deconstructing cerebellar development cell by cell
van Essen, M. J., Nayler, S., Becker, E. B. E., & Jacob, J. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008630 · Cited by 66
Gene regulatory network inference in single-cell biology
Akers, K., & Murali, T. M. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.04.007 · Cited by 68
Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment
Hodis, E., Triglia, E. T., Kwon, J., Biancalani, T., Zakka, L. R., Parkar, S., Hütter, J.-C., Buffoni, L., Delorey, T. M., Phillips, D., et al. (2022) · Science · doi:10.1126/science.abi8175 · Cited by 61
Self-citationOvercoming Acquired Epigenetic Resistance to BTK Inhibitors
Shaffer, A. L., Phelan, J. D., Wang, J. Q., Huang, D., Wright, G. W., Kasbekar, M., Choi, J., Young, R. M., Webster, D. E., Yang, Y., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0063 · Cited by 68
Evaluating the Utilities of Foundation Models in Single‐Cell Data Analysis
Liu, T., Li, K., Wang, Y., Li, H., & Zhao, H. (2026) · Advanced Science · doi:10.1002/advs.202514490 · Cited by 91
Paolillo, C., Londin, E. R., & Fortina, P. M. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2017.283895 · Cited by 63
STARRPeaker: uniform processing and accurate identification of STARR-seq active regions
Lee, D., Shi, M., Moran, J. R., Wall, M., Zhang, J., Liu, J. J., Fitzgerald, D., Kyono, Y., Ma, L., White, K. P., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02194-x · Cited by 59
Evaluating the Utilities of Foundation Models in Single-cell Data Analysis
Liu, T., Li, K., Wang, Y., Li, H., & Zhao, H. (2023) · doi:10.1101/2023.09.08.555192 · Cited by 62
Quantitative single-cell transcriptomics
Ziegenhain, C., Vieth, B., Parekh, S., Hellmann, I., & Enard, W. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/ely009 · Cited by 60
Defining the Teratoma as a Model for Multi-lineage Human Development
McDonald, D., Wu, Y., Dailamy, A., Tat, J., Parekh, U., Zhao, D., Hu, M. Y., Tipps, A. M. P., Zhang, K., & Mali, P. (2020) · Cell · doi:10.1016/j.cell.2020.10.018 · Cited by 60
Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease
Luquez, T., Gaur, P., Kosater, I. M., Lam, M., Lee, D. I., Mares, J. A., Paryani, F., Yadav, A., & Menon, V. (2022) · Genome Medicine · doi:10.1186/s13073-022-01136-5 · Cited by 64
Base editing screens define the genetic landscape of cancer drug resistance mechanisms
Coelho, M. A., Strauß, M. E., Watterson, A., Cooper, S., Bhosle, S. G., Illuzzi, G., Karakoç, E., Dinçer, C., Vieira, S. F., Sharma, M., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01948-8 · Cited by 65
Drugs of abuse hijack a mesolimbic pathway that processes homeostatic need
Tan, B., Browne, C. J., Nöbauer, T., Vaziri, A., Friedman, J. M., & Nestler, E. J. (2024) · Science · doi:10.1126/science.adk6742 · Cited by 61
Mammalian Synthetic Biology: Engineering Biological Systems
Black, J. B., Pérez‐Piñera, P., & Gersbach, C. A. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044649 · Cited by 60
Ušaj, M. M., Sahin, N., Friesen, H., Pons, C., Ušaj, M., Masinas, M. P. D., Shuteriqi, E., Shkurin, A., Aloy, P., Morris, Q., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199243 · Cited by 57
Pooled genetic perturbation screens with image-based phenotypes
Feldman, D., Funk, L., Le, A., Carlson, R. J., Leiken, M. D., Tsai, F., Soong, B., Singh, A., & Blainey, P. C. (2022) · Nature Protocols · doi:10.1038/s41596-021-00653-8 · Cited by 59
Investigating Tumor Heterogeneity in Mouse Models
Tammela, T., & Sage, J. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033413 · Cited by 61
Macrophage heterogeneity and energy metabolism
Verdeguer, F., & Aouadi, M. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.043 · Cited by 58
Permutation-based Causal Inference Algorithms with InterventionsPreprint
Wang, Y., Solus, L., Yang, K., & Uhler, C. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1705.10220 · Cited by 59
Exploiting epigenetic dependencies in ovarian cancer therapy
Coughlan, A. Y., & Testa, G. (2021) · International Journal of Cancer · doi:10.1002/ijc.33727 · Cited by 58
Kim, H. S., Kweon, J., & Kim, Y. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01212-3 · Cited by 68
Jiang, L., Dalgarno, C., Papalexi, E., Mascio, I., Wessels, H., Yun, H., Iremadze, N., Lithwick‐Yanai, G., Lipson, D., & Satija, R. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01622-z · Cited by 77
Kim, H. S., Lee, K., Kim, S., Cho, S., Shin, H. J., Kim, C., & Kim, J. (2018) · Genome Research · doi:10.1101/gr.230250.117 · Cited by 61
Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap
Gu, J., Iyer, A., Wesley, B., Taglialatela, A., Leuzzi, G., Hangai, S., Decker, A., Gu, R., Klickstein, N., Shuai, Y., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02386-x · Cited by 69
Data navigation on the ENCODE portal
Kagda, M. S., Lam, B. R., Litton, C., Small, C., Sloan, C. A., Spragins, E., Tanaka, F. Y., Whaling, I., Gabdank, I., Youngworth, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64343-9 · Cited by 92
CRISPR-Based Tools in Immunity
Simeonov, D. R., & Marson, A. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041522 · Cited by 57
Osteoarthritis year in review: genetics, genomics, epigenetics
Young, D. A., Barter, M. J., & Soul, J. (2021) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2021.11.004 · Cited by 57
Zhou, W., Gao, F., Romero-Wolf, M., Jo, S., & Rothenberg, E. V. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm1920 · Cited by 52
Sharma, S., & Petsalaki, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040933 · Cited by 54
Yu, J., Peng, J., & Chi, H. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.03.003 · Cited by 61
Novel insights into inner ear development and regeneration for targeted hearing loss therapies
Roccio, M., Senn, P., & Heller, S. (2019) · Hearing Research · doi:10.1016/j.heares.2019.107859 · Cited by 58
Graph representation learning for single-cell biology
Hetzel, L., Fischer, D. S., Günnemann, S., & Theis, F. J. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.05.008 · Cited by 55
Xu, Z., Sziraki, A., Lee, J., Zhou, W., & Cao, J. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01948-9 · Cited by 52
Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection
Dobrindt, K., Hoagland, D. A., Seah, C., Kassim, B. S., O’Shea, C. P., Murphy, A., Iskhakova, M., Fernando, M. B., Powell, S. K., Deans, P. J. M., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.010 · Cited by 53
Integrating machine learning and genome editing for crop improvement
Chen, L., Liu, G., & Zhang, T. (2024) · aBIOTECH · doi:10.1007/s42994-023-00133-5 · Cited by 60
Leveraging Single-Cell Approaches in Cancer Precision Medicine
Nath, A., & Bild, A. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.01.007 · Cited by 57
Single-Cell Applications of Next-Generation SequencingPreprint
Anaparthy, N., Ho, Y.-J., Martelotto, L. G., Hammell, M., & Hicks, J. B. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026898 · Cited by 55
A mini-review on perturbation modelling across single-cell omic modalities
Gavriilidis, G. I., Vasileiou, V., Orfanou, A., Ishaque, N., & Psomopoulos, F. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.058 · Cited by 54
Single-cell RNA-seq methods to interrogate virus-host interactions
Ratnasiri, K., Wilk, A. J., Lee, M. J., Khatri, P., & Blish, C. A. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00972-2 · Cited by 56
Neurodegeneration cell per cell
Balusu, S., Praschberger, R., Lauwers, E., Strooper, B. D., & Verstreken, P. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.016 · Cited by 53
Multiplexed single-cell characterization of alternative polyadenylation regulators
Kowalski, M. H., Wessels, H., Linder, J., Dalgarno, C., Mascio, I., Choudhary, S., Hartman, A., Hao, Y., Kundaje, A. B., & Satija, R. (2024) · Cell · doi:10.1016/j.cell.2024.06.005 · Cited by 56
Integration of single-cell multi-omics for gene regulatory network inference
Hu, X., Hu, Y., Wu, F., Leung, R. W. T., & Qin, J. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.033 · Cited by 55
Single-cell manifold-preserving feature selection for detecting rare cell populations
Liang, S., Mohanty, V., Dou, J., Miao, Q., Huang, Y., Müftüoğlu, M., Ding, L., Peng, W., & Chen, K. (2021) · Nature Computational Science · doi:10.1038/s43588-021-00070-7 · Cited by 53
Generating and Using Transcriptomically Based Retinal Cell Atlases
Shekhar, K., & Sanes, J. R. (2021) · Annual Review of Vision Science · doi:10.1146/annurev-vision-032621-075200 · Cited by 51
Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations
Hsiung, C. C. ‐., Wilson, C. M., Sambold, N. A., Dai, R., Chen, Q., Teyssier, N., Misiukiewicz, S., Arab, A., O’Loughlin, T. A., Cofsky, J. C., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02224-0 · Cited by 55
Degrons: defining the rules of protein degradation
Zhang, Z., Mena, E. L., Timms, R. T., Koren, I., & Elledge, S. J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00870-z · Cited by 67
Leveraging large genomic datasets to illuminate the pathobiology of autism spectrum disorders
Searles, V. B., Wang, B., & State, M. W. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0768-y · Cited by 53
Massively parallel techniques for cataloguing the regulome of the human brain
Townsley, K. G., Brennand, K., & Huckins, L. M. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00740-1 · Cited by 52
Moving from in vitro to in vivo CRISPR screens
Kuhn, M., Santinha, A. J., & Platt, R. J. (2021) · Gene and Genome Editing · doi:10.1016/j.ggedit.2021.100008 · Cited by 56
Plant single-cell solutions for energy and the environment
Cole, B., Bergmann, D. C., Blaby, C., Blaby, I. K., Bouchard, K. E., Brady, S. M., Ciobanu, D., Coleman‐Derr, D., Leiboff, S., Mortimer, J. C., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02477-4 · Cited by 52
Kim, S. S., Truong, B., Jagadeesh, K., Dey, K. K., Shen, A. Z., Raychaudhuri, S., Kellis, M., & Price, A. L. (2024) · Nature Communications · doi:10.1038/s41467-024-44742-0 · Cited by 56
Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing
Simmons, S., Lithwick‐Yanai, G., Adiconis, X., Oberstrass, F. C., Iremadze, N., Geiger-Schuller, K., Thakore, P. I., Frangieh, C. J., Barad, O., Almogy, G., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01452-6 · Cited by 56
Self-citationscPRINT: pre-training on 50 million cells allows robust gene network predictions
Kalfon, J., Samaran, J., Gabriel Peyré, A., & Cantini, L. (2025) · Nature Communications · doi:10.1038/s41467-025-58699-1 · Cited by 76
Network Approaches for Dissecting the Immune System
Shi, H., Yan, K., Ding, L., Qian, C., Chi, H., & Yu, J. (2020) · iScience · doi:10.1016/j.isci.2020.101354 · Cited by 51
Advances in Genomics for Drug Development
Spreafico, R., Soriaga, L. B., Grosse, J., Virgin, H. W., & Telenti, A. (2020) · Genes · doi:10.3390/genes11080942 · Cited by 56
Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Duran-Frigola, M., Cigler, M., & Winter, G. E. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11098 · Cited by 50
Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells
Ásgrímsdóttir, E. S., & Arenas, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00463 · Cited by 54
T cell metabolism in homeostasis and cancer immunity
Wei, J., Zheng, W., Chapman, N. M., Geiger, T. L., & Chi, H. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.02.003 · Cited by 52
Shiau, F., Ruzycki, P. A., & Clark, B. S. (2021) · Developmental Biology · doi:10.1016/j.ydbio.2021.06.005 · Cited by 51
Artificial neural networks enable genome-scale simulations of intracellular signaling
Nilsson, A., Peters, J. M., Meimetis, N., Bryson, B. D., & Lauffenburger, D. A. (2022) · Nature Communications · doi:10.1038/s41467-022-30684-y · Cited by 57
McCalla, S. G., Siahpirani, A. F., Li, J., Pyne, S., Stone, M., Periyasamy, V., Shin, J., & Roy, S. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad004 · Cited by 56
Scalable co-sequencing of RNA and DNA from individual nuclei
Olsen, T. R., Talla, P., Sagatelian, R., Furnari, J. L., Bruce, J. N., Canoll, P., Zha, S., & Sims, P. A. (2025) · Nature Methods · doi:10.1038/s41592-024-02579-x · Cited by 50
Mocciaro, A., Roth, T. L., Bennett, H. M., Soumillon, M., Shah, A., Hiatt, J. B., Chapman, K., Marson, A., & Lavieu, G. (2018) · Communications Biology · doi:10.1038/s42003-018-0034-6 · Cited by 49
Ovarian cancer and the evolution of subtype classifications using transcriptional profiling†
Cook, D. P., & Vanderhyden, B. C. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz099 · Cited by 50
Impact of CRISPR interference on strain development in biotechnology
Schultenkämper, K., Brito, L. F., & Wendisch, V. F. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1901 · Cited by 57
Feldman, D., Singh, A., Garrity, A. J., & Blainey, P. C. (2018) · doi:10.1101/262121 · Cited by 49
Massively parallel assessment of human variants with base editor screens
Hanna, R. E., Hegde, M., Fagre, C. R., DeWeirdt, P. C., Sangree, A. K., Szegletes, Z., Griffith, A., Feeley, M. N., Sanson, K. R., Baidi, Y., et al. (2020) · doi:10.1101/2020.05.17.100818 · Cited by 314
“…screens require only a short sequencing read, they are theoretically compatible with alternative pooled screening readouts, such as single-cell RNA sequencing (Datlinger et al., 2017; Dixit et al., 2016; Hill et al., 2018; Replogle et al., 2020) and pooled optical screens (Feldman et al., 2019).”
geneBasis: an iterative approach for unsupervised selection of targeted gene panels from scRNA-seq
Missarova, A., Jain, J., Butler, A., Ghazanfar, S., Stuart, T., Brusko, M., Wasserfall, C. H., Nick, H. S., Brusko, T. M., Atkinson, M. A., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02548-z · Cited by 47
Modeling the complex genetic architectures of brain disease
Fernando, M. B., Ahfeldt, T., & Brennand, K. (2020) · Nature Genetics · doi:10.1038/s41588-020-0596-3 · Cited by 48
Learning interpretable cellular responses to complex perturbations in high-throughput screensPreprint
Lotfollahi, M., Klimovskaia, A., Donno, C. D., Ji, Y., Ibarra, I. L., Wolf, F. A., Yakubova, N., Theis, F. J., & López-Paz, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.14.439903 · Cited by 49
Yang, Y., Li, G., Zhong, Y., Xu, Q., Chen, B.-J., Lin, Y.-T., Chapkin, R. S., & Cai, J. J. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad450 · Cited by 48
Revisiting Cardiac Biology in the Era of Single Cell and Spatial Omics
Palmer, J. A., Rosenthal, N. A., Teichmann, S. A., & Litviňuková, M. (2024) · Circulation Research · doi:10.1161/circresaha.124.323672 · Cited by 48
BROCKMAN: deciphering variance in epigenomic regulators by k-mer factorization
de Boer, C. G., & Regev, A. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2255-6 · Cited by 47
Self-citationCo-expression in Single-Cell Analysis: Saving Grace or Original Sin?
Crow, M., & Gillis, J. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.07.007 · Cited by 48
Profiling Chromatin Accessibility at Single-Cell Resolution
Sinha, S., Satpathy, A. T., Zhou, W., Ji, H., Stratton, J. A., Jaffer, A., Bahlis, N. J., Morrissy, A. S., & Biernaskie, J. A. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.06.010 · Cited by 49
Identifying transcriptional programs underlying cancer drug response with TraCe-seq
Chang, M. T., Shanahan, F., Nguyen, T. T. T., Staben, S. T., Gazzard, L. J., Yamazoe, S., Wertz, I. E., Piskol, R., Yang, Y. A., Modrusan, Z. D., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01005-3 · Cited by 42
Metadata
- Authors
- Dixit, A., Parnas, O., Li, B., Chen, J., Fulco, C. P., Jerby-Arnon, L., Marjanovic, N. D., Dionne, D., Burks, T., Raychowdhury, R., Adamson, B., Norman, T. M., Lander, E. S., Weissman, J. S., Friedman, N., & Regev, A.
- Affiliations
- Broad Institute (US)
- QB3 (US)
- Corresponding author
- Regev, Aviv
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 167
- Issue
- 7
- Pages
- 1853-1866.e17
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5181115
- OpenAlex
- W2561754210
- Cited by
- 1,863
- References
- 64
- Citations by year
- 2026: 324 · 2025: 279 · 2024: 229 · 2023: 195 · 2022: 180 · 2021: 169 · 2020: 159 · 2019: 126 · 2018: 107 · 2017: 87 · 2016: 2
- FWCI
- 55.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- Funders
- NDSEG Fellowship
- NIH (T32GM87232)
- Klarman Cell Observatory
- NHGRI (RM1HG006193)
- HHMI
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Keywords
- Perturb-seq, single-cell RNA sequencing, gene expression profiling, gene regulatory networks, transcription factor regulation, dendritic cells, lipopolysaccharide response, immune activation, genetic interactions, mitochondrial function, antiviral response
- MeSH terms
- Animals, Cell Cycle, Feedback, Humans, Mice, Transgenic, Transcription Factors, Sequence Analysis, RNA, K562 Cells, Gene Expression Profiling, Mice, Gene Knockdown Techniques, Single-Cell Analysis, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
